Julia Sangiovanni
Medical · Chicago, ILNPI 1184288722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,009 and has fallen 63.7% since, to $729 in 2025.
Across 221 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$682
- AbbVie$579
- Supernus Pharmaceuticals, Inc.$317
- AstraZeneca$278
- Lilly USA, LLC$267
- Amarin Pharma, Inc.$239
- plus $2K from 36 others
What the payments were for
- Food & beverage$4,565100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $682 |
| AbbVie | 28 | $579 |
| Supernus Pharmaceuticals, Inc. | 7 | $317 |
| AstraZeneca | 16 | $278 |
| Lilly USA, LLC | 14 | $267 |
| Amarin Pharma, Inc. | 13 | $239 |
| Tris Pharma Inc | 8 | $162 |
| Exact Sciences | 6 | $144 |
| Pfizer | 6 | $139 |
| Johnson & Johnson | 7 | $131 |
| GSK | 7 | $112 |
| Gilead | 4 | $110 |
| Amgen | 6 | $110 |
| Neos Therapeutics, LP | 5 | $97 |
| Esperion Therapeutics, Inc. | 6 | $93 |
| Corium, LLC | 4 | $90 |
| Dexcom, Inc. | 2 | $86 |
| Mylan Specialty L.p. | 3 | $84 |
| Merck | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Viiv Healthcare Company | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 4 | $46 |
| Bayer | 2 | $44 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Vistapharm, Inc. | 3 | $43 |
| Jazz Pharmaceuticals Inc. | 3 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Corcept Therapeutics | 1 | $35 |
| Noven Therapeutics, LLC | 2 | $34 |
| Eisai Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Boehringer Ingelheim | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Organon | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Vivus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$193
How this compares
$4,565 in reported general payments places this provider in the 85th percentile of 449 medical providers in Illinois.
Other medical in Chicago
- Andrea TurekChicago$145K
- Jennifer GarsonChicago$32K
- William KvasnickaChicago$19K
- Brittany WolfeChicago$12K
- Eric KingChicago$9K
- Neema ManappuramChicago$8K
- Robert RadtkeChicago$7K
- Koree RamseyChicago$5K
- Justin OkrayChicago$5K
- Alexis DavidmanChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.